Low disease activity key to reducing adverse pregnancy outcomes in women with SLE
Adverse pregnancy outcomes more frequently occur among women with systemic lupus erythematosus (SLE), results of a study have shown. SLE patients are then advised to delay pregnancy until they achieve Lupus Low Disease Activity State (LLDAS) and to closely monitor pregnancies with the lowest possible dose of corticosteroid (CS).
